Showing results (141-150 of 232) with videos related to

Sort By:
Pageof 24
European Journal of Gastroenterology & Hepatology|November 13, 2019
Clostridium difficile caused changes in fatty acids profile and resolvin D1 content in plasma of infected patientsMirosław Dróżdż, Joanna Gdula-Argasińska, Grażyna Biesiada, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 9, 2018
The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertensionTomasz Pizoń, Marek Rajzer, Wiktoria Wojciechowska, et al.
Blood Cancer Journal|March 22, 2022
Extramedullary disease in multiple myeloma: a systematic literature reviewJoan Bladé, Meral Beksac, Jo Caers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2018
The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significanceKrzysztof Batko, Jolanta Malyszko, Artur Jurczyszyn, et al.
ACS Applied Electronic Materials|November 16, 2020
High-Entropy Perovskites as Multifunctional Metal Oxide Semiconductors: Synthesis and Characterization of (Gd0.2Nd0.2La0.2Sm0.2Y0.2)CoO3Paweł A Krawczyk, Michał Jurczyszyn, Jakub Pawlak, et al.
Cell Death & Disease|February 25, 2021
Suppression of steroid 5α-reductase type I promotes cellular apoptosis and autophagy via PI3K/Akt/mTOR pathway in multiple myelomaRenjie Dou, Jinjun Qian, Wei Wu, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 29, 2024
Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in "real-world" study: Experiences of the Polish Myeloma GroupGrzegorz Charliński, Aneta Szudy-Szczyrek, Martyna Podgajna, et al.
Advances in Medical Sciences|September 12, 2020
Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma GroupAleksandra Gołos, Lidia Gil, Bartosz Puła, et al.
Pharmacological Reports : PR|April 20, 2019
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysisMonika Długosz-Danecka, Iwona Hus, Bartosz Puła, et al.
Polish Archives of Internal Medicine|April 28, 2021
Risk factors and causes of early mortality in patients with newly diagnosed multiple myeloma in a "real-world" study: experiences of the Polish Myeloma GroupGrzegorz Charliński, Agata Tyczyńska, Bartosz Małecki, et al.
Pageof 24